Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer

L. Tiainen; M. Hämäläinen; T. Luukkaala; M. Tanner; O. Lahdenperä; P. Vihinen; A. Jukkola; P. Karihtala; E. Moilanen; P.-L. Kellokumpu-Lehtinen

doi:10.1016/j.clbc.2019.03.006

Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer

L. Tiainen
, M. Hämäläinen
, T. Luukkaala
, M. Tanner
, O. Lahdenperä
, P. Vihinen
, A. Jukkola
, P. Karihtala
, E. Moilanen
, P.-L. Kellokumpu-Lehtinen

Health Sciences

Research output: Contribution to journal › Article › Scientific › peer-review

38 Citations (Scopus)

Original language	English
Pages (from-to)	e522-e533
Journal	Clinical Breast Cancer
Volume	19
Issue number	4
DOIs	https://doi.org/10.1016/j.clbc.2019.03.006
Publication status	Published - 2019
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Bevacizumab
First-line chemotherapy treatment
Interleukin 8
Metastatic breast cancer
Prognosis

Publication forum classification

Publication forum level 1

Access to Document

10.1016/j.clbc.2019.03.006

http://urn.fi/urn:nbn:fi:tuni-201909093201

Cite this

Tiainen, L., Hämäläinen, M., Luukkaala, T., Tanner, M., Lahdenperä, O., Vihinen, P., Jukkola, A., Karihtala, P., Moilanen, E., & Kellokumpu-Lehtinen, P.-L. (2019). Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer. Clinical Breast Cancer, 19(4), e522-e533. https://doi.org/10.1016/j.clbc.2019.03.006

@article{a1f394f64165457e890392fcb8978e4b,

title = "Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer",

keywords = "Bevacizumab, First-line chemotherapy treatment, Interleukin 8, Metastatic breast cancer, Prognosis, Bevacizumab, First-line chemotherapy treatment, Interleukin 8, Metastatic breast cancer, Prognosis",

author = "L. Tiainen and M. H{\"a}m{\"a}l{\"a}inen and T. Luukkaala and M. Tanner and O. Lahdenper{\"a} and P. Vihinen and A. Jukkola and P. Karihtala and E. Moilanen and P.-L. Kellokumpu-Lehtinen",

year = "2019",

doi = "10.1016/j.clbc.2019.03.006",

language = "English",

volume = "19",

pages = "e522--e533",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

publisher = "Elsevier",

number = "4",

}

Tiainen, L, Hämäläinen, M, Luukkaala, T , Tanner, M, Lahdenperä, O, Vihinen, P, Jukkola, A, Karihtala, P, Moilanen, E & Kellokumpu-Lehtinen, P-L 2019, 'Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer', Clinical Breast Cancer, vol. 19, no. 4, pp. e522-e533. https://doi.org/10.1016/j.clbc.2019.03.006

TY - JOUR

T1 - Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer

AU - Tiainen, L.

AU - Hämäläinen, M.

AU - Luukkaala, T.

AU - Tanner, M.

AU - Lahdenperä, O.

AU - Vihinen, P.

AU - Jukkola, A.

AU - Karihtala, P.

AU - Moilanen, E.

AU - Kellokumpu-Lehtinen, P.-L.

PY - 2019

Y1 - 2019

KW - Bevacizumab

KW - First-line chemotherapy treatment

KW - Interleukin 8

KW - Metastatic breast cancer

KW - Prognosis

KW - Bevacizumab

KW - First-line chemotherapy treatment

KW - Interleukin 8

KW - Metastatic breast cancer

KW - Prognosis

U2 - 10.1016/j.clbc.2019.03.006

DO - 10.1016/j.clbc.2019.03.006

M3 - Article

SN - 1526-8209

VL - 19

SP - e522-e533

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

IS - 4

ER -